EX-31.4 3 apre-20221231xex31d4.htm EX-31.4

Exhibit 31.4

CERTIFICATION OF PERIODIC REPORT

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John Hamill, certify that:

1.

I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Aprea Therapeutics, Inc. for the year ended December 31, 2022; and

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report

​

​

​

Date: April 28, 2023

​

​

​

​

​

​

​

/s/ John P. Hamill

​

​

John P. Hamill

​

​

Chief Financial Officer

​

​

(Principal Financial Officer)

​